Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management “Labcorp is the only reference laboratory to offer stinging insect (venom) component testing,” ...
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of ...
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com "Clinicians are under increasing pressure to do more with less," said Dr. Brian Caveney, Labcorp's ...
The biomarker test measures NfL levels through standard blood collection. Labcorp has launched the Neurofilament Light Chain (NfL) blood test to identify and verify signs of neuronal damage related to ...
BURLINGTON, N.C.--(BUSINESS WIRE)--There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Labcorp, the Burlington-based global life sciences company ...
BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results